Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68788-8684

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68788-8684). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin Calcium Tablets Usp 20 mg (5327cf20 81e0 4b46 8c86 88c0ddd19c5f 00)

Label for Atorvastatin Calcium Tablets USP 20 mg, a film-coated tablet generic for Lipitor. The label includes manufacturer Annora Pharma Pvt. Ltd. and directions for use in English and Spanish. It shows storage instructions and warnings, as well as spaces for lot, batch, and prescription information. The label is primarily black text on white with a prominent yellow section for dosage directions.*

FDA Label Image

Atorvastatinfigure1. (Atorvastatinfigure1)

Chemical structure of atorvastatin calcium, as represented in the image. It shows the molecular arrangement including aromatic rings, hydroxyl groups, and calcium ion coordination as part of the calcium salt form of atorvastatin.*

FDA Label Image

Atorvastatinfigure2. (Atorvastatinfigure2)

A line graph comparing cumulative incidence percentages over approximately 3.5 years for Atorvastatin and Placebo groups. The x-axis represents time in years, and the y-axis shows cumulative incidence percentage. The graph displays separate lines for Atorvastatin (lower line) and Placebo (higher line), indicating differences in cumulative incidence between the two groups over time.*

FDA Label Image

Atorvastatinfigure3. (Atorvastatinfigure3)

A line graph showing cumulative hazard percentages over a 5-year follow-up for Atorvastatin versus placebo. The x-axis represents time in years to the first primary endpoint, with two lines where Atorvastatin maintains a lower cumulative hazard compared to placebo. A hazard ratio (HR) with confidence intervals and p-value are noted on the graph.*

FDA Label Image

Atorvastatinfigure4. (Atorvastatinfigure4)

A line chart illustrating the time to first major cardiovascular endpoint (in years) with subjective event percentages on the vertical axis. The chart compares Atorvastatin 10 mg and Atorvastatin 80 mg over a 5-year period, showing different event rates for both dosages.*

FDA Label Image

Atorvastatin Calcium Tablets Usp 10mg (Atorvastatinfigure5)

Atorvastatin Calcium Tablets USP 10 mg film-coated tablet label from Preferred Pharmaceuticals, Inc. The label indicates it is generic for Lipitor and each tablet contains 10 mg atorvastatin equivalent to 10.825 mg atorvastatin calcium trihydrate. The packaging includes a section for directions in English and Spanish, barcode, and caution about federal law prohibiting transfer of the drug. Manufacturer is listed as Annora Pharma Pvt. Ltd.*

FDA Label Image

Atorvastatinfigure9 (Atorvastatinfigure9)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.